The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
H H S Department of Health and Human Services
Health Resources and Services Administration
Blood Cell Transplant

A-Z Index  |  Questions?  |  Order Publications

Donor Registry Transplant Data

Data about transplants using unrelated marrow donors and umbilical cord blood units from the donor registry of the C.W. Bill Young Cell Transplantation Program (Program), including the National Cord Blood Inventory, are reported annually.

These data include the number of transplants performed along with the following information:

  • Diagnoses for which transplants have been performed most often, including blood cancers such as leukemia and lymphoma as well as myelodysplastic syndromes.
  • Cell sources used for transplants: bone marrow, peripheral blood stem cells (PBSC), and umbilical cord blood.
  • The age, race, and ethnic heritage of patients who received transplants.

On this page:

Figure 1. Growth in Number of Registry Transplants 

Figure 1. Growth in Number of Registry Transplants.

View larger image, Detailed Description [D]

Since the registry was established in 1987, it has facilitated more than 61,000 marrow and cord blood transplants for patients who do not have a matching donor in their family. In 2013, the registry facilitated nearly 6,300 transplants, an increase of almost 500 transplants over the previous year.

Figure 2. Registry Transplants by Patient Diagnosis 

Figure 2. Registry Transplants by Patient Diagnosis.
 
View larger image, Detailed Description [D]

The blood cancers (hematologic malignancies) for which patients received an unrelated bone marrow or cord blood unit transplant most often during 2013 were:

  • Acute Myelogenous Leukemia (AML): 35%
  • Acute Lymphoblastic Leukemia (ALL): 14%
  • MyelodysplasticSyndromes (MDS): 17%
  • Non-Hodgkin Lymphoma (NHL): 10%
  • Other Leukemias, including Juvenile Leukemias and Chronic Lymphocytic Leukemia (OL): 5%
  • Chronic Myelogenous Leukemia (CML): 3%
  • Hodgkin Lymphoma (HL): 3%

The number of transplants continues to increase, with the largest areas of growth in AML, ALL, MDS and NHL.

Figure 3. Registry Transplants by Patient Age 

View larger image, Detailed Description [D]

In 2013, children (0 to 17 years) received 19 percent of transplants, adults 18 to 50 years received 36 percent of transplants, adults 51 to 64 years received 31 percent of transplants, and adults over age 65 received 14 percent of transplants.

Figure 4. Registry Transplants by Patient Race* 

Figure 4a.
American Indian or
Alaska Native Race

Figure 4a. American Indian or Alaska Native Race.

View larger image
Detailed Description [D]

Figure 4b.
Asian Race

Figure 4b. Asian Race.

View larger image
Detailed Description [D]

Figure 4c.
Black or African American Race

Figure 4c. Black or African American Race.

View larger image
Detailed Description [D]

Figure 4d.
White Race

Figure 4d. White Race.

View larger image
Detailed Description [D]

Figure 4e.
Native Hawaiian or
Pacific Islander Race

Figure 4e. Native Hawaiian or Pacific Islander Race.

View larger image
Detailed Description [D]

 

For the last several years, transplants have increased steadily for patients of most races.

Figure 5. Registry Transplants by Patient Ethnicity* 

Figure 5. Registry Transplants by Patient Ethnicity.

View larger image, Detailed Description [D]

Since 2005, transplants for patients who reported their ethnicity as Hispanic or Latino has remained steady, often increasing.

Figure 6. Registry Transplants by Cell Source 

Figure 6. Registry Transplants by Cell Source.

View larger image, Detailed Description [D]

During 2013, cord blood units were used in 1,102 transplants. The National Cord Blood Inventory provided 714 cord blood units for these transplants.

Also, 1,292 transplants were performed using bone marrow and more than 3,889 transplants used peripheral blood stem cells.

Figure 7. Role of Cord Blood in Registry Transplants by Patient Race* 

Figure 7. Role of Cord Blood in Registry Transplants by Patient Race.

View larger image, Detailed Description [D]

In 2013, cord blood was used to help 31 percent of patients from all races who received a transplant.

Figure 8. Role of Cord Blood in Registry Transplants by Patient Ethnicity* 

Figure 8. Role of Cord Blood in Registry Transplants by Patient Ethnicity.

View larger image, Detailed Description [D]

Nearly one third of patients who recorded their ethnicity as Hispanic or Latino received a cord blood transplant.

*Patients are asked to record both their race and ethnicity. Patients who indicated their ethnicity as Hispanic or Latino are also included in the race data.

Donor Registry Data

The Program’s donor registry, also called the Be The Match Registry®, is operated under Federal contracts by the National Marrow Donor Program® (NMDP). Donor registry data are reported from Oct. 1 - Sept. 30 by the NMDP.

Patient Outcomes

Find more information about patient survival using marrow donors or donated cord blood units from the registry.

Successful Outcomes Depend on a Matching Donor